TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Aprea Therapeutics AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
17
|
16 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-486
|
-5,565
|
-10,911 |
| EBITDA |
-510
|
-5,563
|
-11,170 |
| Total assets |
1,577
|
1,605
|
5,937 |
| Current assets |
1,568
|
1,595
|
5,914 |
| Current liabilities |
720
|
854
|
4,193 |
| Equity capital |
858
|
751
|
1,637 |
| - share capital |
858
|
855
|
931 |
| Employees (average) |
1
|
6
|
9 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
54.4%
|
46.8%
|
27.6% |
| Turnover per employee |
0
|
3
|
2 |
| Profit as a percentage of turnover |
-32735.3%
|
-68193.8% | |
| Return on assets (ROA) |
-30.8%
|
-346.7%
|
-183.8% |
| Current ratio |
217.8%
|
186.8%
|
141.0% |
| Return on equity (ROE) |
-56.6%
|
-741.0%
|
-666.5% |
| Change turnover |
-17
|
2
|
1 |
| Change turnover % |
-100%
|
16%
|
4% |
| Chg. No. of employees |
-5
|
-3
|
0 |
| Chg. No. of employees % |
-83%
|
-33%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.